Form 4 for CALC CalciMedica, Inc.
Accepted 2023-11-08 00:00:00 ET · period of report 2023-11-07 · accession 0001209191-23-054770 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-08 | 2023-11-07 | CALC | Leheny A. Rachel | CEO, Dir, 10% | P - Purchase | $3.34 | +2,000 | 18.8K | +12% | +$6,680 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-07 | P | A | 2,000 | $3.34 | 18,840 | D | — | — | (F1) The weighted average purchase price for the transaction reported was $3.34, and the range of prices were between $3.30 and $3.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |